规划环境影响评价中公众参与有效性的探讨

公众参与在规划环境影响评价中具有重要的意义。目前环境影响评价中公众参与中存在许多不足，严重影响了公众参与的有效性，在提高规划环境影响评价中公众参与制度的有效性、信息发布的有效性、参与对象的有效性、参与方法的有效性以及结论有效性等方面提出了建议。     

北京市冬季公共场所室内空气中TSP, PM10, PM2.5和PM1污染研究

在北京市的海淀区、朝阳区、丰台区和昌平区选择了 49个公共场所 (包括办公室、宾馆、图书馆、超市等等 ) ,分别对其室内空气中TSP ,PM10 ,PM2 5 和PM1的浓度进行了测定 ,并且对室内空气中粉尘含量的影响因素进行了分析和探讨 .研究结果表明 ,繁忙的交通状况和建筑施工将明显增加公共场所室内空气中TSP ,PM10 ,PM2 5 和PM1浓度 .频繁的室内清扫有助于降低室内空气中颗粒物的浓度 .在室内空气中 ,PM10 浓度与TSP浓度呈现明显的正向线性相关性 ,而PM2 5 和PM1的浓度与PM10 浓度的相关性较差     

我国可持续设计及其实践的探讨

可持续设计超越了传统设计和生态设计，要求平衡经济、环境、社会３方面的发展需要，在可持续设计的基本工具产品生命周期评价尚需进一步发展的同时，建立适当的设计准则是当前发展可持续设计的可行途径。     

西湖底泥不同供氧条件下有机质降解及CO2与CH4释放速率的模拟研究

采用密闭培养实验装置于室温（２５℃左右）及ｐＨ为７５条件下，对西湖底泥中有机质完全降解及转化为ＣＯ２和ＣＨ４的速率进行了模拟研究．结果表明，在西湖湖水现有供氧水平（５０—８６ｍｇ（Ｏ２）／Ｌ）条件下，底泥中有机质完全降解的速率最为缓慢，培养期间（４２天）平均只有０７２ｍｇ（Ｃ）／（ｋｇ·ｄ）．当湖水供氧水平进一步上升（８６→１２０→１６０ｍｇ（Ｏ２）／Ｌ），ＣＯ２释放速率增加，最大值可达到８７ｍｇ（Ｃ）／（ｋｇ·周）；当湖水供氧水平下降（８６→０ｍｇ（Ｏ２）／Ｌ），ＣＨ４释放速率加快，最大值可达到４６ｍｇ（Ｃ）／（ｋｇ·周）．     

乙醇废水的超临界水氧化反应路径及动力学研究

研究了超临界水氧化法 (SCWO)处理乙醇废水过程的反应路径和动力学 .乙醇SCWO反应的最终产物为CO2 ,CO是此过程的中间产物 .以幂指数方程描述乙醇SCWO反应动力学 ,得到对于乙醇的反应级数为 1,对氧气的反应级数为 0 .求出活化能和指前因子分别为 3 5 1× 10 5J·mol-1和 7 74× 10 2 1s-1.方程计算值和实验值吻合较好 ,误差基本在 10 %以内     

Mechanisms of granular activated carbon anaerobic fluidized-bed process for treating phenols wastewater

ＩｎｔｒｏｄｕｃｔｉｏｎＢｅｆｏｒｅｔｈｅ 1 980ｓｃｏｎｖｅｎｔｉｏｎａｌｔｒｅａｔｍｅｎｔｐｒｏｃｅｓｓｅｓｏｆｐｈｅｎｏｌｓｗａｓｔｅｗａｔｅｒａｒｅｓｏｌｖｅｎｔｅｘｔｒａｃｔｉｏｎ ,ｐｈｙｓｉｃａｌａｄｓｏｒｐｔｉｏｎ ,ｃｈｅｍｉｃａｌｏｘｉｄａｔｉｏｎａｎｄａｅｒｏｂｉｃｂｉｏｌｏｇｉｃａｌｐｒｏｃｅｓｓ.Ａｍｏｎｇｔｈｅｂｉｏｌｏｇｉｃａｌｕｎｉｔｐｒｏｃｅｓｓｅｓａｃｔｉｖａｔｅｄｓｌｕｄｇｅｐｒｏｃｅｓｓｉｓｍａｉｎｏｎｅ.Ａｆｔｅｒｔｈｅ 1 980ｓａｎａｅｒｏｂｉｃｂｉｏｌｏｇｉｃ…     

马铃薯淀粉废水的碱式聚合氧化铝处理

本文介绍了用碱式聚合氯化铝处理高浓度有机淀粉废水的效果。用实验室配制的CODw浓度为10000－15000mg/L的淀粉废水以不同用量的碱式聚合氯化铝为絮凝剂处理后，CODw去除率达到28％－47％，再经吸附柱吸附后，CODw去除率可达到65％。     

有机磷酸酯诱导迟发性神经毒性及其对神经毒性酯酶(NTE)活性影响的动态研究

以成年产卵来航母鸡为试验动物，研究了三甲基苯基磷酸酯诱导的迟发性神经毒性。试验发现，母鸡口服ＴＯＣＰ后经过大约８－１０ｄ的潜伏期开始出现中毒症状，其表现为以步态失调为主要特征的运动障碍呈进行性加重，至２１ｄ开始便发展为瘫痪。     

MSAFP levels and oesophageal atresia

This study was undertaken to evaluate the relationship between maternal serum alpha-fetoprotein (MSAFP) levels and oesophageal atresia (OA). OA occurred in 16 fetuses of mothers who had an MSAFP test in the study interval. The multiple of the median (MOM) value for MSAFP averaged 1·54 ± 0·65 (range 0·5–2·9 MOM), which was significantly higher than the value seen in controls. The median MOM was 1·35. Using a cut-off of 2·5 MOM, the sensitivity of MSAFP for detecting OA was 19 per cent. Although OA should be considered in the differential diagnosis of an elevated MSAFP level, MSAFP cannot be considered an appropriate screening test for OA given the low sensitivity.     

Dystrophin protein and rflp analyis for fetal diagnosis and carrier confirmation of duchenne muscular dystrophy

A pregnant woman with indeterminate Duchenne muscular dystrophy (DMD) carrier status, but with DMD diagnosed in her deceased brother (unavailable for study), presented for prenatal diagnosis, intending to continue the pregnancy only if proven unaffected with DMD with near absolute certainty. Creatine kinase (CK) assays to clarify carrier status were inconclusive. Male sex in the fetus was identified, but DNA restriction fragment length polymorphism (RFLP) analysis was not yet available to this centre to investigate the possible transmission of the DMD gene, and the pregnancy was terminated. Tissue histology and dystrophin protein analysis demonstrated the absence of DMD. In a situation with proven maternal carrier status, future fetal inheritance of the opposite maternal X chromosome would indicate the presence of DMD. However, maternal carrier status remained in doubt through a second pregnancy, even with RFLP studies, and was finally established when dystrophin analysis confirmed the presence of DMD in the second fetus. Histologic findings are presented, contrasting features in the two fetuses. The value of dystrophin analysis for establishing the diagnosis of fetal DMD, in this case proving maternal carrier status in a difficult situation, and for demonstrating DMD gene:RFLP haplotype relationships is illustrated.